TITLE

Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes

AUTHOR(S)
Poloni, A; Maurizi, G; Mattiucci, D; Amatori, S; Fogliardi, B; Costantini, B; Mariani, M; Mancini, S; Olivieri, A; Fanelli, M; Leoni, P
PUB. DATE
November 2014
SOURCE
Leukemia (08876924);Nov2014, Vol. 28 Issue 11, p2241
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the evidence that changes to the direct interaction between hematopoietic stem cells (HSCs) and stroma contribute to abnormal HSC growth and maturation. The use of flow cytometry to compare the expression of molecules that have important functions in cell adhesion such as CD90, CD44 and CD29, and mesenchymal markers, such as CD105 and CD73 is stated. The reduced proliferative capacity showed by Myelodysplastic syndromes (MDS) and Mesenchymal stem cells (MSCs) is cited.
ACCESSION #
99881554

 

Related Articles

  • Plasticity and Maintenance of Hematopoietic Stem Cells During Development. Kanji, Suman; Pompili, Vincent J.; Das, Hiranmoy // Recent Patents on Biotechnology;Apr2011, Vol. 5 Issue 1, p40 

    Maintenance of hematopoietic stem cells (HSCs) pool depends on fine balance between self-renewal and differentiation of HSCs. HSCs normally reside within the bone marrow niche of an adult mammal. The embryonic development of HSCs is a complex process that involves the migration of developing...

  • Peripheral Blood Stem Cells: Phenotypic Diversity and Potential Clinical Applications. Zhang, Yichi; Huang, Bing // Stem Cell Reviews & Reports;Sep2012, Vol. 8 Issue 3, p917 

    A small proportion of cells in peripheral blood are actually pluripotent stem cells. These peripheral blood stem cells (PBSCs) are thought to be heterogeneous and could be exploited for a variety of clinical applications. The exact number of distinct populations is unknown. It is likely that...

  • The Heterogeneous HLA Genetic Makeup of the Swiss Population. Buhler, Stéphane; Nunes, José Manuel; Nicoloso, Grazia; Tiercy, Jean-Marie; Sanchez-Mazas, Alicia // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    This study aims at investigating the HLA molecular variation across Switzerland in order to determine possible regional differences, which would be highly relevant to several purposes: optimizing donor recruitment strategies in hematopoietic stem cell transplantation (HSCT), providing reliable...

  • Potential Uses for Cord Blood Mesenchymal Stem Cells. Zarrabi, Morteza; Mousavi, Seyed Hadi; Abroun, Saeid; Sadeghi, Bahareh // Cell Journal (Yakhteh);Winter2014, Vol. 15 Issue 4, p274 

    Stem cell therapy is a powerful technique for the treatment of a number of diseases. Stem cells are derived from different tissue sources, the most important of which are the bone marrow (BM), umbilical cord (UC) blood and liver. Human UC mesenchymal stem cells (hUC-MSCs) are multipotent,...

  • ParacrineMolecules ofMesenchymal Stem Cells for Hematopoietic StemCell Niche. Tian Li; Yaojiong Wu // Bone Marrow Research;2011, p1 

    Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are both adult stem cells residing in the bone marrow. MSCs interact with HSCs, they stimulate and enhance the proliferation of HSCs by secreting regulatory molecules and cytokines, providing a specialized microenvironment for...

  • Isolation and characterization of mesenchymal stem cells from human bone marrow. Qing Cong; Yan Xu; Yinghuang Wang; Wei Jiang; Yisheng Wang; Bin Li; Congjian Xu // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p12904 

    Objective: Human bone marrow mesenchymal stem cells (BMSCs) offer therapeutic potential for a broad range of diseases. Different approaches for the isolation of human BMSCs have been described, including the simple removal of non-adherent cells after 48 hours, density gradient centrifugation,...

  • A revised scheme for developmental pathways of hematopoietic cells: the myeloid-based model. Kawamoto, Hiroshi; Wada, Haruka; Katsura, Yoshimoto // International Immunology;Feb2010, Vol. 22 Issue 2, p65 

    Blood cells comprise very diverse cell types with a wide range of crucial functions; however, they share a common progenitor cell type—the hematopoietic stem cell (HSC). Clarifying how HSCs differentiate into these diverse cell types is important for understanding how they attain their...

  • Controlling stem cell fate one substrate at a time. Garrison, Brian S.; Rossi, Derrick J. // Nature Immunology;Mar2010, Vol. 11 Issue 3, p193 

    The article focuses on the research by researcher L. Reavie and his colleagues regarding the role of the ubiquitinproteasome system in determining hematopoietic stem cell (HSC) fate. They propose a stem cell regulation in which modulation of protein stability by the ubiquitin system is used to...

  • Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes. Kastrinaki, Maria-Christina; Pontikoglou, Charalampos; Klaus, Mirjam; Stavroulaki, Emily; Pavlaki, Konstantia; Papadaki, Helen A. // Current Stem Cell Research & Therapy;Jun2011, Vol. 6 Issue 2, p122 

    Myelodysplastic syndromes comprise a heterogeneous group of clonal hematopoietic stem cell malignancies characterized by ineffective bone marrow (BM) hematopoiesis, peripheral blood cytopenias and substantial risk for progression to acute myeloid leukemia. It is generally accepted that...

Share

Other Topics